In this nested case–control study, subjects who later developed IBD had signs of low-grade systemic inflammation, indicated by significantly higher CRP plasma levels in CD and lower albumin plasma levels in UC, before the onset of clinical disease. This evidence concerns the gene CRP and inflammatory bowel disease.